WEEKLY VERSUS TRI|WEEKLY CONCURRENT CISPLATIN WITH ...

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent ...

The standard dose of 100 mg/m2 cisplatin every 3 weeks is associated with clinically significant toxicity.

Weekly versus triweekly cisplatin-based concurrent ...

Hu et al subsequently conducted a meta-analysis to evaluate the efficacy of weekly and triweekly cisplatin combined with RT for the treatment of ...

3-weekly or weekly cisplatin concurrently with radiotherapy for ...

Significantly more patients receive a cumulative cisplatin dose of ≥200 mg/m 2 , when treated with a 3-weekly schedule compared to weekly dosing.

Three Weekly Versus Weekly Cisplatin: Comparison of two Different ...

Methodology: Our study retrospectively compares the 3-weekly and the weekly concurrent cisplatin schedules in patients of LAHNC treated with CRT ...

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent ...

Cisplatin every 3 weeks versus weekly with definitive concurrent radiotherapy for squamous cell carcinoma of the head and neck.

Weekly Versus Triweekly Cisplatin in the Treatment of Patients with ...

Both weekly and triweekly cisplatin are appropriate options when combined with concurrent radiotherapy in HNSCC patients. Neither dosing ...

An open-label, noninferiority phase III RCT of weekly versus three ...

Background: CCRT using 3 weekly cisplatin (DDP) 100mg/m2 is considered standard nonsurgical option for LAHNSCC.

Concurrent chemoradiotherapy with cisplatin given once-a-week ...

The authors concluded that every three-weekly cisplatin provides superior loco-regional disease control, albeit with higher acute toxicity compared to once-a- ...

Phase III randomized trial comparing weekly versus three-weekly ...

Background: Chemoradiation (CRT) with cisplatin 100mg/m2 given 3-weekly is the standard of care in locally advanced head and neck squamous ...

Concurrent Chemoradiation Therapy With Weekly Cisplatin for ...

When combined with radiotherapy as definitive treatment of locally advanced head and neck squamous cell carcinoma, cisplatin at a dose of 40 ...

Concurrent weekly cisplatin versus triweekly ... - Oxford Academic

Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective ...

Weekly vs. tri-weekly cisplatin based chemoradiation in carcinoma ...

Background: Addition of chemotherapy to radiation has improved 5-year survival by 6%. However, the optimal dose and schedule of concurrent ...

Weekly Versus Triweekly Cisplatin-Based Chemotherapy ...

Conclusions Weekly cisplatin regimen had the similar therapeutic effect as the triweekly cisplatin regimen but with less hematologic toxicity. Therefore, we ...

Concurrent Weekly Cisplatin Versus Triweekly Cisplatin Alone with ...

Conclusion. Triweekly single platinum chemotherapy plus concurrent RT significantly improved the compliance of patients with LACC, and reduced the local ...

A comparison of weekly versus 3-weekly cisplatin during concurrent ...

Concurrent cisplatin-based chemotherapy administered weekly or three-weekly in combination with IMRT leads to similar acute toxicities and long-term survival ...

Concurrent chemoradiotherapy with weekly versus triweekly ...

Weekly cisplatin was comparable in efficacy and safety to the triweekly regimen. Our analysis supports the use of weekly or triweekly cisplatin ...

A multicenter randomized phase II trial (KCSG-HN10-02)

Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A ...

Weekly versus triweekly cisplatin plus intensity-modulated ...

Conclusion: IMRT concurrent with a weekly cisplatin regimen was associated with significantly improved distant metastasis-free survival in locally advanced NPC.

Comparison of standard-dose 3-weekly cisplatin and low-dose

Standard treatment for locally advanced (stage III-IV) head and neck squamous cell cancer (LA-HNSCC) is concurrent chemoradiation therapy (CCRT) with cisplatin ...

A meta-analysis of weekly cisplatin versus three weekly ... - Oncotarget

Many studies have confirmed that cisplatin acted as a radiosensitizer and cisplatin-based concurrent CRT had more toxicity than radiotherapy ...